Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06222671
PHASE2

A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

View on ClinicalTrials.gov

Summary

This study will evaluate the effect and safety of 608 in patients with nr-axSpA.

Official title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Study to Evaluate the Efficacy and Safety of 608 in Patients With Non-radiographic Axial Spondyloarthritis (Nr-axSpA)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2024-03-22

Completion Date

2025-11-30

Last Updated

2025-03-11

Healthy Volunteers

No

Interventions

DRUG

608

608 subcutaneous (SC) injection.

DRUG

608

608 subcutaneous (SC) injection.

DRUG

Placebo

Placebo subcutaneous (SC) injection.

Locations (6)

Site 01

Beijing, Beijing Municipality, China

Site 03

Beijing, Beijing Municipality, China

Site 05

Chongqing, Chongqing Municipality, China

Site 02

Zhengzhou, Henan, China

Site 04

Nanjing, Jiangsu, China

Site 06

Shenzhen, Shenzhen, China